Drug Profile
Estradiol/desogestrel - Organon
Alternative Names: Estradiol + desogestrel - OrganonLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Organon
- Developer Schering-Plough
- Class Estradiol congeners; Estrenes; Hormonal replacements; Norpregnenes
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Menopausal syndrome
Most Recent Events
- 19 Nov 2007 Organon has been acquired and merged into Schering-Plough
- 19 Nov 1999 Launched for Menopausal syndrome in Europe (PO)
- 19 Nov 1999 Registered for Menopausal syndrome in Europe (PO)